Cite
HARVARD Citation
Lu, J. et al. (2020). Pyoderma gangrenosum: proposed pathogenesis and current use of biologics with an emphasis on complement C5a inhibitor IFX-1. Expert opinion on investigational drugs. pp. 1179-1185. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lu, J. et al. (2020). Pyoderma gangrenosum: proposed pathogenesis and current use of biologics with an emphasis on complement C5a inhibitor IFX-1. Expert opinion on investigational drugs. pp. 1179-1185. [Online].